HIF-prolyl hydroxylase is a potential molecular target for esculetin-mediated anti-colitic effects.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Fitoterapia

• Publication date

  2015-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.fitote.2015.03.013PMID 25797536
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Colon-targeted celecoxib ameliorates TNBS-induced rat colitis: a potential pharmacologic mechanism and therapeutic advantages.

  2014cited by this paper
• Antioxidant and intestinal anti-inflammatory effects of plant-derived coumarin derivatives.

  2014cited by this paper
• Piceatannol, a hydroxystilbene natural product, stabilizes HIF-1α protein by inhibiting HIF prolyl hydroxylase.

  2013cited by this paper
• Colon-targeted cell-permeable NFκB inhibitory peptide is orally active against experimental colitis.

  2012cited by this paper
• Molecular mechanisms of epithelial regeneration and neovascularization during healing of gastric and esophageal ulcers.

  2012cited by this paper
• Simultaneous determination of esculin and its metabolite esculetin in rat plasma by LC-ESI-MS/MS and its application in pharmacokinetic study.

  2012cited by this paper
• Caffeic acid phenethyl ester is a potent inhibitor of HIF prolyl hydroxylase: structural analysis and pharmacological implication.

  2010cited by this paper
• Intestinal anti-inflammatory activity of esculetin and 4-methylesculetin in the trinitrobenzenesulphonic acid model of rat colitis.

  2010cited by this paper
• Loss of prolyl hydroxylase-1 protects against colitis through reduced epithelial cell apoptosis and increased barrier function.

  2010cited by this paper
• Targeting hypoxia-inducible factor-1 (HIF-1) signaling in therapeutics: implications for the treatment of inflammatory bowel disease.

  2009cited by this paper
• The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis.

  2008cited by this paper
• Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition.

  2008cited by this paper
• Mucosal protection by hypoxia‐inducible factor (HIF) prolyl hydroxylase inhibition

  2008cited by this paper
• Quercetin Activates an Angiogenic Pathway, Hypoxia Inducible Factor (HIF)-1-Vascular Endothelial Growth Factor, by Inhibiting HIF-Prolyl Hydroxylase: a Structural Analysis of Quercetin for Inhibiting HIF-Prolyl Hydroxylase

  2007cited by this paper
• Natural and synthetic coumarin derivatives with anti-inflammatory/ antioxidant activities.

  2004cited by this paper
• Relation of Hypoxia-Inducible Factor-1α to Vascular Endothelial Growth Factor and Vasoactive Factors During Healing of Gastric Ulcers

  2004cited by this paper
• Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancer.

  2004cited by this paper
• Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis.

  2004cited by this paper
• Characterization of the Human Prolyl 4-Hydroxylases That Modify the Hypoxia-inducible Factor*

  2003cited by this paper
• Hsp90 Regulates a von Hippel Lindau-independent Hypoxia-inducible Factor-1α-degradative Pathway*

  2002cited by this paper
• Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway.

  2002cited by this paper
• A Conserved Family of Prolyl-4-Hydroxylases That Modify HIF

  2001cited by this paper
• Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation

  2001cited by this paper
• HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing

  2001cited by this paper
• Mechanism of regulation of the hypoxia‐inducible factor‐1α by the von Hippel‐Lindau tumor suppressor protein

  2000cited by this paper
• Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway.

  1998cited by this paper
• Regulation of hypoxia-inducible factor 1α is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway

  1998cited by this paper
• Hypoxia-inducible factor 1: master regulator of O2 homeostasis.

  1998cited by this paper
• Protein hydroxylation: prolyl 4‐hydroxylase, an enzyme with four cosubstrates and a multifunctional subunit

  1989cited by this paper

• Unveiling the Potential of Esculetin in Cancer Models and Chemotherapy‐Induced Toxicity: Mechanistic Insights From Preclinical Evidence

  2026cites this paper
• Antioxidant and anti‑inflammatory effects of esculin and esculetin (Review)

  2024cites this paper
• Therapeutic potential of natural coumarins in autoimmune diseases with underlying mechanisms

  2024cites this paper
• In-vitro and in-vivo evaluation and anti-colitis activity of esculetin-loaded nanostructured lipid carrier decorated with DSPE-MPEG2000

  2023cites this paper
• Pharmacological activities of esculin and esculetin: A review

  2023cites this paper
• Phytochemistry and health functions of Zanthoxylum bungeanum Maxim and Zanthoxylum schinifolium Sieb. et Zucc as pharma-foods: A systematic review

  2023cites this paper
• Natural Coumarin Derivatives Activating Nrf2 Signaling Pathway as Lead Compounds for the Design and Synthesis of Intestinal Anti-Inflammatory Drugs

  2023influential citation
• Deciphering the pharmacological mechanisms of Fraxini Cortex for ulcerative colitis treatment based on network pharmacology and in vivo studies

  2023cites this paper
• Pharmacological and Therapeutic Applications of Esculetin

  2022influential citation
• Artemisia scoparia and Metabolic Health: Untapped Potential of an Ancient Remedy for Modern Use

  2022cites this paper
• Investigation of the active ingredients and pharmacological mechanisms of Porana sinensis Hemsl. Against rheumatoid arthritis using network pharmacology and experimental validation

  2022cites this paper
• Esculetin: A review of its pharmacology and pharmacokinetics

  2021cites this paper
• The role of hypoxia‐inducible factor 1‐alpha in inflammatory bowel disease

  2021cites this paper
• Coumarin Derivatives in Inflammatory Bowel Disease

  2021influential citation
• Chemopreventive potential of esculetin in 7,12-dimethylbenz(a)anthracene-induced hamster buccal pouch carcinogenesis

  2018cites this paper
• Topical administration of Esculetin as a potential therapy for experimental dry eye syndrome

  2017cites this paper
• Regulation of monocyte anti-thrombotic gene and protein expression through platelet-derived material

  2016cites this paper